Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Tanja VukajlovicClara O SailerAli AsmarBoye L JensenDeborah R VogtMirjam Christ-CrainBettina WinzelerPublished in: The Journal of clinical endocrinology and metabolism (2022)
In euvolemic participants, a 3-week treatment of dulaglutide reduced systolic blood pressure independently of plasma renin, ANG II, or aldosterone levels and urinary sodium excretion. The reduction in MR-proANP might be secondary to reduced arterial pulse pressure.